These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22781487)

  • 41. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immediate evidence of the benefit of distal protection in vein graft intervention.
    Porto I; Cautilli G; Camaioni C
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):828-9. PubMed ID: 21670703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
    Vaknin-Assa H; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1055-7. PubMed ID: 19434749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Export aspiration catheter-enhanced FilterWire delivery: an innovative strategy for treatment of saphenous vein graft disease.
    Jim MH; Ho HH; Chow WH
    J Invasive Cardiol; 2006 Nov; 18(11):569-74. PubMed ID: 17090825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease.
    Costa MA; Gigliotti OS; Zenni MM; Gilmore PS; Bass TA
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):368-75. PubMed ID: 14988898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current percutaneous treatment strategies for saphenous vein graft disease.
    Marmagkiolis K; Grines C; Bilodeau L
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter by Alfonso et al regarding article, "Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis".
    Alfonso F; Dutary J; Zakhem B
    Circ Cardiovasc Interv; 2009 Oct; 2(5):e3; author reply E4. PubMed ID: 20031742
    [No Abstract]   [Full Text] [Related]  

  • 50. Intracoronary stent placement in thrombus containing vein graft lesions.
    Kaul U; Agarwal R; Mathur A; Wasir HS
    J Invasive Cardiol; 1995 Oct; 7(8):248-50. PubMed ID: 10158117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fractional flow reserve assessment of the unprotected left main artery: a case of the cart before the horse?
    Ormerod JO; Ramcharitar S
    Future Cardiol; 2013 Nov; 9(6):779-83. PubMed ID: 24180536
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of Proxis for percutaneous coronary intervention in patients with totally occluded saphenous vein grafts: an alternative approach.
    Rutigliano D; Vacca M; Pestrichella V; Contegiacomo G
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):869-74. PubMed ID: 19531960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of embolic protection devices in ostial saphenous vein graft lesions.
    Abdel-Karim AR; Papayannis AC; Mahmood A; Michael TT; Rangan BV; Makke L; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1120-6. PubMed ID: 22422709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of angioplasty (with or without stent) at the site of a narrowed coronary anastomosis of the left internal mammary artery graft or via the internal mammary artery.
    Köckeritz U; Reynen K; Knaut M; Strasser RH
    Am J Cardiol; 2004 Jun; 93(12):1531-3. PubMed ID: 15194028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hinge motion and excessive negative remodeling as a cause of early saphenous vein graft failure.
    Kume T; Okura H; Fukuhara K; Koyama T; Nezuo S; Neishi Y; Hayashida A; Kawamoto T; Tanemoto K; Yoshida K
    JACC Cardiovasc Interv; 2013 Mar; 6(3):e15-6. PubMed ID: 23517849
    [No Abstract]   [Full Text] [Related]  

  • 57. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C
    J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary endarterectomy and stent removal after iatrogenic perforation.
    Fukui T; Takanashi S; Mihara W; Ishikawa K; Hosoda Y
    Ann Thorac Surg; 2004 Feb; 77(2):708-11. PubMed ID: 14759470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guiding-catheter thrombectomy combined with distal protection during primary percutaneous coronary intervention of a saphenous vein graft.
    García-Tejada J; Jurado-Román A; Hernández F; Asenjo RM; de Nicolás JM; Albarrán A; Velázquez M; Tascón J
    Cardiovasc Revasc Med; 2013; 14(6):356-8. PubMed ID: 24267597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
    Abizaid A; Weiner B; Bailey SR; Londero H
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):781-6. PubMed ID: 20549692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.